1-10 of 10
Joel Greshock
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB-B04: Complex drug combinations can induce apoptotic killing in robust colorectal cancer cells

Thomas Horn, Stéphane Ferretti, Nicolas Ebel, Angela Tam, Samuel Ho, Fred Harbinski, Ali Farsidjani, Matthew Zubrowski, Ensar Halilovic, Erick Morris, William R. Sellers, Robert Schlegel, Jens Wuerthner, Levi A. Garraway, Sébastien Jeay, Joel Greshock, Giordano Caponigro, Joseph Lehár
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): LB-B04.
https://doi.org/10.1158/1535-7163.TARG-15-LB-B04
Published: 01 December 2015
View article titled, Abstract LB-B04: Complex drug combinations can induce apoptotic killing in robust colorectal cancer cells
Journal Articles

Abstract IA17: Exploiting the synthetic lethal properties of selective PI3K-β inhibition in PTEN deficient cells with GSK2636771

Joel Greshock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (5_Supplement): IA17.
https://doi.org/10.1158/1535-7163.PMS-IA17
Published: 01 May 2014
View article titled, Abstract IA17: Exploiting the synthetic lethal properties of selective PI3K-β inhibition in PTEN deficient cells with GSK2636771
Journal Articles

Comprehensive Predictive Biomarker Analysis for MEK Inhibitor GSK1120212

Junping Jing, Joel Greshock, Joanna Dawn Holbrook, Aidan Gilmartin, Xiping Zhang, Elizabeth McNeil, Theresa Conway, Christopher Moy, Sylvie Laquerre, Kurt Bachman, Richard Wooster, Yan Degenhardt
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (3): 720–729.
https://doi.org/10.1158/1535-7163.MCT-11-0505
Published: 06 March 2012
View article titled, Comprehensive Predictive Biomarker Analysis for MEK Inhibitor GSK1120212
Open the PDF for Comprehensive Predictive Biomarker Analysis for MEK Inhibitor GSK1120212 in another window
Includes: Supplementary data
Journal Articles

Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability

Yan Degenhardt, Joel Greshock, Sylvie Laquerre, Aidan G. Gilmartin, Junping Jing, Mark Richter, Xiping Zhang, Maureen Bleam, Wendy Halsey, Ashley Hughes, Christopher Moy, Nancy Liu-Sullivan, Scott Powers, Kurtis Bachman, Jeffrey Jackson, Barbara Weber, Richard Wooster
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (7): 2079–2089.
https://doi.org/10.1158/1535-7163.MCT-10-0095
Published: 07 July 2010
View article titled, Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability
Open the PDF for Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability in another window
Includes: Supplementary data
Journal Articles

Abstract B173: Synergistic interaction between CENP‐E inhibitor GSK923295 and MEK inhibitor GSK1120212

Yan Y. Degenhardt, Xiping Zhang, Christopher Moy, Theresa Conway, Liz Mcneil, Junping Jing, Joel Greshock, Ronald Wegrzyn, Holy Yin, Spyro Mousses, Richard Wooster, Kurtis Bachman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B173.
https://doi.org/10.1158/1535-7163.TARG-09-B173
Published: 10 December 2009
View article titled, Abstract B173: Synergistic interaction between CENP‐E inhibitor GSK923295 and MEK inhibitor GSK1120212
Journal Articles

Abstract B140: In vitro sensitivity profiling identifies selectively responsive tumor types and molecular subtypes to the PI3K inhibitor GSK2126458

Joel Greshock, Mary Ann Hardwicke, Theresa Conway, Yan Degenhardt, Leanne Cartee, Christopher Moy, Joanne Lager, Richard Wooster, Kurtis Bachman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B140.
https://doi.org/10.1158/1535-7163.TARG-09-B140
Published: 10 December 2009
View article titled, Abstract B140: <em>In vitro</em> sensitivity profiling identifies selectively responsive tumor types and molecular subtypes to the PI3K inhibitor GSK2126458
Journal Articles

Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines

Joel Greshock, Jie Cheng, David Rusnak, Anne Marie Martin, Richard Wooster, Tona Gilmer, Kwan Lee, Barbara L. Weber, Tal Zaks
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 935–943.
https://doi.org/10.1158/1535-7163.MCT-07-2072
Published: 15 April 2008
View article titled, Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines
Open the PDF for Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines in another window
Includes: Supplementary data
Journal Articles

Characterizing response to lapatinib (GW572016) in non-Her2 amplified tumor-derived cell lines

Joel greshock, William Cornwell, Yan Degenhardt, Kurtis Bachman, Christopher Moy, David Rusnak, Anne-Marie Martin, Tona Gilmer, Jie Cheng, Kwan Lee, Tal Zaks, Barbara Weber, Richard Wooster
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C142.
Published: 01 November 2007
View article titled, Characterizing response to <em>lapatinib</em> (GW572016) in non-Her2 amplified tumor-derived cell lines
Journal Articles

Association of mutations in the TP53 gene and chromosome instability with sensitivity to the PLK1 inhibitor GSK461364

Richard Wooster, Yan Degenhardt, Joel Greshock, Sylvie Laquerre, Aidan Gilmartin, Kurt Auger, Junping Jing, Ganesh Sathe, Barbara Weber, Jeff Jackson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C130.
Published: 01 November 2007
View article titled, Association of mutations in the TP53 gene and chromosome instability with sensitivity to the PLK1 inhibitor GSK461364
Journal Articles

Biomarkers that predict cancer cell line response to the AKT inhibitor GSK690693

Richard Wooster, Kumar Rakesh, Kurtis Bachman, Joel Greshock, Yan Degenhardt, Kurt Auger, Ganesh Sathe, Dilip Rajagopalan, Barbara Weber
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C129.
Published: 01 November 2007
View article titled, Biomarkers that predict cancer cell line response to the AKT inhibitor GSK690693